The bioabsorbable surgical mesh market size has grown strongly in recent years. It will grow from $1.25 billion in 2025 to $1.36 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limitations of permanent surgical mesh, rising hernia and soft tissue repair surgeries, increased awareness of post-surgical complications, growth in hospital-based surgical procedures, early adoption of absorbable polymers.
The bioabsorbable surgical mesh market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to advancements in bioabsorbable polymer materials, increasing demand for minimally invasive surgeries, rising use of bioactive and drug-eluting meshes, growing surgical volume in aging populations, expanding clinical adoption in specialty surgeries. Major trends in the forecast period include rising adoption of bioabsorbable mesh in hernia repair, growing preference for temporary implants over permanent mesh, increasing use of composite and bioactive mesh materials, focus on reducing post-surgical complications and infections, expansion of minimally invasive surgical procedures.
The increasing number of surgical procedures is expected to drive the growth of the bioabsorbable surgical mesh market in the coming years. Surgical procedures involve medical interventions that intentionally alter body structures, usually by cutting or repairing tissue, to treat, diagnose, or prevent diseases, injuries, or other conditions. The rise in surgical procedures is mainly due to the growing prevalence of chronic diseases such as cardiovascular diseases, cancer, and obesity-related disorders. Bioabsorbable surgical mesh supports these procedures by providing temporary reinforcement to healing tissues and gradually dissolving, which lowers the risk of long-term complications related to permanent implants. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures performed worldwide. Therefore, the growing volume of surgical procedures is fueling the expansion of the bioabsorbable surgical mesh market.
Key players in the bioabsorbable surgical mesh market are concentrating on creating advanced products like fully bioabsorbable pocket and strap designs to improve ease of placement and fixation during hernia repair surgeries. These designs incorporate absorbable structural components within the mesh, enabling accurate positioning and lateral fixation without the need for permanent implants. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device firm, introduced the Phasix ST Umbilical Hernia Patch. This is the first fully absorbable hernia patch specifically made for umbilical hernias, featuring a pocket and strap configuration made from poly-4-hydroxybutyrate (P4HB), a biologically derived polymer. The design mimics the handling and placement of permanent mesh but is entirely absorbed by the body over time. The patch also contains a hydrogel barrier using Sepra Technology to reduce tissue adhesion. Available in various sizes, it addresses a wide range of umbilical hernia defects and meets growing demand for non-permanent, patient-focused solutions in soft tissue reconstruction.
In February 2024, RTI Surgical Inc., a US-based healthcare technology company, completed the acquisition of Cook Biotech Incorporated for an undisclosed sum. Through this acquisition, RTI Surgical seeks to strengthen its regenerative medicine contract development and manufacturing capabilities by incorporating Cook Biotech’s porcine small intestinal submucosa (SIS) platform and biomaterials into its allograft and xenograft offerings. Cook Biotech Incorporated is a US-based biotechnology firm that focuses on developing and producing SIS-derived extracellular matrix scaffolds and biomaterial products for a wide range of clinical applications.
Major companies operating in the bioabsorbable surgical mesh market are Johnson And Johnson, Medtronic plc, Integra LifeSciences Holdings Corporation, B Braun Melsungen AG, Advanced Medical Solutions Group plc, TELA Bio Inc, Kerecis Limited, W L Gore And Associates Inc, Assut Europe S p A, BioHealth Medical Technology Co Ltd, Aroa Biosurgery Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, Aran Biomedical Teoranta, Deep Blue Medical Advances Inc, Meccellis Biotech, PrintBio Inc, Atrium Medical Corporation, Cousin Biotech, Surgical Mesh Technologies Inc, Gore Medical Bioabsorbables, MedSkin Solutions Dr Suwelack AG.
North America was the largest region in the bioabsorbable surgical mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioabsorbable surgical mesh market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioabsorbable surgical mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bioabsorbable surgical mesh market by increasing costs for imported raw materials such as polylactic acid, polyglycolic acid, and composite biomaterials. Product segments including composite and bioactive meshes are most impacted, particularly in Asia-Pacific and European regions that rely on cross-border material sourcing. These cost pressures have influenced pricing and procurement strategies across hospitals and surgical centers. However, tariffs have also encouraged localized manufacturing, supply chain diversification, and innovation in alternative bioabsorbable materials, supporting long-term market stability.
The bioabsorbable surgical mesh market research report is one of a series of new reports that provides bioabsorbable surgical mesh market statistics, including bioabsorbable surgical mesh industry global market size, regional shares, competitors with a bioabsorbable surgical mesh market share, detailed bioabsorbable surgical mesh market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable surgical mesh industry. This bioabsorbable surgical mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bioabsorbable surgical mesh is a medical implant crafted from materials that gradually degrade and are absorbed by the body, providing temporary support to tissues during the healing process. These meshes are commonly used in surgeries like hernia repair and soft tissue reinforcement, helping to avoid permanent implants and reducing the risk of long-term complications.
The main categories of bioabsorbable surgical mesh include polymer-based mesh, composite mesh, and bioactive mesh. Polymer-based mesh consists of synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), or their copolymers. Materials used include polylactic acid, polyglycolic acid, polycaprolactone, composite materials, and natural polymers. These products are distributed through channels like direct sales, online platforms, distributors, and wholesalers. They find applications in hernia repair, dural repair, urological surgery, cardiovascular surgery, orthopedic surgery, and more, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and research institutions.
The bioabsorbable surgical mesh market consists of sales of collagen-based meshes, polyglycolic acid (PGA) meshes, polylactic acid (PLA) meshes, polycaprolactone (PCL) meshes, and composite bioabsorbable meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The bioabsorbable surgical mesh market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to advancements in bioabsorbable polymer materials, increasing demand for minimally invasive surgeries, rising use of bioactive and drug-eluting meshes, growing surgical volume in aging populations, expanding clinical adoption in specialty surgeries. Major trends in the forecast period include rising adoption of bioabsorbable mesh in hernia repair, growing preference for temporary implants over permanent mesh, increasing use of composite and bioactive mesh materials, focus on reducing post-surgical complications and infections, expansion of minimally invasive surgical procedures.
The increasing number of surgical procedures is expected to drive the growth of the bioabsorbable surgical mesh market in the coming years. Surgical procedures involve medical interventions that intentionally alter body structures, usually by cutting or repairing tissue, to treat, diagnose, or prevent diseases, injuries, or other conditions. The rise in surgical procedures is mainly due to the growing prevalence of chronic diseases such as cardiovascular diseases, cancer, and obesity-related disorders. Bioabsorbable surgical mesh supports these procedures by providing temporary reinforcement to healing tissues and gradually dissolving, which lowers the risk of long-term complications related to permanent implants. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures performed worldwide. Therefore, the growing volume of surgical procedures is fueling the expansion of the bioabsorbable surgical mesh market.
Key players in the bioabsorbable surgical mesh market are concentrating on creating advanced products like fully bioabsorbable pocket and strap designs to improve ease of placement and fixation during hernia repair surgeries. These designs incorporate absorbable structural components within the mesh, enabling accurate positioning and lateral fixation without the need for permanent implants. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device firm, introduced the Phasix ST Umbilical Hernia Patch. This is the first fully absorbable hernia patch specifically made for umbilical hernias, featuring a pocket and strap configuration made from poly-4-hydroxybutyrate (P4HB), a biologically derived polymer. The design mimics the handling and placement of permanent mesh but is entirely absorbed by the body over time. The patch also contains a hydrogel barrier using Sepra Technology to reduce tissue adhesion. Available in various sizes, it addresses a wide range of umbilical hernia defects and meets growing demand for non-permanent, patient-focused solutions in soft tissue reconstruction.
In February 2024, RTI Surgical Inc., a US-based healthcare technology company, completed the acquisition of Cook Biotech Incorporated for an undisclosed sum. Through this acquisition, RTI Surgical seeks to strengthen its regenerative medicine contract development and manufacturing capabilities by incorporating Cook Biotech’s porcine small intestinal submucosa (SIS) platform and biomaterials into its allograft and xenograft offerings. Cook Biotech Incorporated is a US-based biotechnology firm that focuses on developing and producing SIS-derived extracellular matrix scaffolds and biomaterial products for a wide range of clinical applications.
Major companies operating in the bioabsorbable surgical mesh market are Johnson And Johnson, Medtronic plc, Integra LifeSciences Holdings Corporation, B Braun Melsungen AG, Advanced Medical Solutions Group plc, TELA Bio Inc, Kerecis Limited, W L Gore And Associates Inc, Assut Europe S p A, BioHealth Medical Technology Co Ltd, Aroa Biosurgery Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, Aran Biomedical Teoranta, Deep Blue Medical Advances Inc, Meccellis Biotech, PrintBio Inc, Atrium Medical Corporation, Cousin Biotech, Surgical Mesh Technologies Inc, Gore Medical Bioabsorbables, MedSkin Solutions Dr Suwelack AG.
North America was the largest region in the bioabsorbable surgical mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioabsorbable surgical mesh market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioabsorbable surgical mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the bioabsorbable surgical mesh market by increasing costs for imported raw materials such as polylactic acid, polyglycolic acid, and composite biomaterials. Product segments including composite and bioactive meshes are most impacted, particularly in Asia-Pacific and European regions that rely on cross-border material sourcing. These cost pressures have influenced pricing and procurement strategies across hospitals and surgical centers. However, tariffs have also encouraged localized manufacturing, supply chain diversification, and innovation in alternative bioabsorbable materials, supporting long-term market stability.
The bioabsorbable surgical mesh market research report is one of a series of new reports that provides bioabsorbable surgical mesh market statistics, including bioabsorbable surgical mesh industry global market size, regional shares, competitors with a bioabsorbable surgical mesh market share, detailed bioabsorbable surgical mesh market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable surgical mesh industry. This bioabsorbable surgical mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Bioabsorbable surgical mesh is a medical implant crafted from materials that gradually degrade and are absorbed by the body, providing temporary support to tissues during the healing process. These meshes are commonly used in surgeries like hernia repair and soft tissue reinforcement, helping to avoid permanent implants and reducing the risk of long-term complications.
The main categories of bioabsorbable surgical mesh include polymer-based mesh, composite mesh, and bioactive mesh. Polymer-based mesh consists of synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), or their copolymers. Materials used include polylactic acid, polyglycolic acid, polycaprolactone, composite materials, and natural polymers. These products are distributed through channels like direct sales, online platforms, distributors, and wholesalers. They find applications in hernia repair, dural repair, urological surgery, cardiovascular surgery, orthopedic surgery, and more, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and research institutions.
The bioabsorbable surgical mesh market consists of sales of collagen-based meshes, polyglycolic acid (PGA) meshes, polylactic acid (PLA) meshes, polycaprolactone (PCL) meshes, and composite bioabsorbable meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Bioabsorbable Surgical Mesh Market Characteristics
3. Bioabsorbable Surgical Mesh Market Supply Chain Analysis
4. Global Bioabsorbable Surgical Mesh Market Trends and Strategies
5. Bioabsorbable Surgical Mesh Market Analysis of End Use Industries
7. Global Bioabsorbable Surgical Mesh Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Bioabsorbable Surgical Mesh Total Addressable Market (TAM) Analysis for the Market
9. Bioabsorbable Surgical Mesh Market Segmentation
10. Bioabsorbable Surgical Mesh Market Regional and Country Analysis
11. Asia-Pacific Bioabsorbable Surgical Mesh Market
12. China Bioabsorbable Surgical Mesh Market
13. India Bioabsorbable Surgical Mesh Market
14. Japan Bioabsorbable Surgical Mesh Market
15. Australia Bioabsorbable Surgical Mesh Market
16. Indonesia Bioabsorbable Surgical Mesh Market
17. South Korea Bioabsorbable Surgical Mesh Market
18. Taiwan Bioabsorbable Surgical Mesh Market
19. South East Asia Bioabsorbable Surgical Mesh Market
20. Western Europe Bioabsorbable Surgical Mesh Market
21. UK Bioabsorbable Surgical Mesh Market
22. Germany Bioabsorbable Surgical Mesh Market
23. France Bioabsorbable Surgical Mesh Market
24. Italy Bioabsorbable Surgical Mesh Market
25. Spain Bioabsorbable Surgical Mesh Market
26. Eastern Europe Bioabsorbable Surgical Mesh Market
27. Russia Bioabsorbable Surgical Mesh Market
28. North America Bioabsorbable Surgical Mesh Market
29. USA Bioabsorbable Surgical Mesh Market
30. Canada Bioabsorbable Surgical Mesh Market
31. South America Bioabsorbable Surgical Mesh Market
32. Brazil Bioabsorbable Surgical Mesh Market
33. Middle East Bioabsorbable Surgical Mesh Market
34. Africa Bioabsorbable Surgical Mesh Market
36. Bioabsorbable Surgical Mesh Market Competitive Landscape and Company Profiles
37. Bioabsorbable Surgical Mesh Market Other Major and Innovative Companies
40. Bioabsorbable Surgical Mesh Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Bioabsorbable Surgical Mesh Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses bioabsorbable surgical mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bioabsorbable surgical mesh? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioabsorbable surgical mesh market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Polymer-Based Mesh; Composite Mesh; Bioactive Mesh2) By Material Type: Polylactic Acid; Polyglycolic Acid; Polycaprolactone; Composite Materials; Natural Polymers
3) By Distribution Channel: Direct Sales; Online Sales; Distributors And Wholesalers
4) By Application: Hernia Repair; Dural Repair; Urological Surgery; Cardiovascular Surgery; Orthopedic Surgery; Other Applications
5) By End-Use: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research Institutions
Subsegments:
1) By Polymer-Based Mesh: Polyglycolic Acid (PGA) Mesh; Polylactic Acid (PLA) Mesh; Polycaprolactone (PCL) Mesh; Polydioxanone (PDO) Mesh2) By Composite Mesh: Polymer-Collagen Composite Mesh; Polymer-Coated Composite Mesh; Synthetic-Biological Composite Mesh; Polymer-Hydrogel Composite Mesh
3) By Bioactive Mesh: Antimicrobial-Embedded Mesh; Growth Factor-Embedded Mesh; Drug-Eluting Mesh; Stem Cell-Seeded Mesh
Companies Mentioned: Johnson And Johnson; Medtronic plc; Integra LifeSciences Holdings Corporation; B Braun Melsungen AG; Advanced Medical Solutions Group plc; TELA Bio Inc; Kerecis Limited; W L Gore And Associates Inc; Assut Europe S p A; BioHealth Medical Technology Co Ltd; Aroa Biosurgery Limited; Cook Biotech Incorporated; Tissue Regenix Group plc; Aran Biomedical Teoranta; Deep Blue Medical Advances Inc; Meccellis Biotech; PrintBio Inc; Atrium Medical Corporation; Cousin Biotech; Surgical Mesh Technologies Inc; Gore Medical Bioabsorbables; MedSkin Solutions Dr Suwelack AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Bioabsorbable Surgical Mesh market report include:- Johnson And Johnson
- Medtronic plc
- Integra LifeSciences Holdings Corporation
- B Braun Melsungen AG
- Advanced Medical Solutions Group plc
- TELA Bio Inc
- Kerecis Limited
- W L Gore And Associates Inc
- Assut Europe S p A
- BioHealth Medical Technology Co Ltd
- Aroa Biosurgery Limited
- Cook Biotech Incorporated
- Tissue Regenix Group plc
- Aran Biomedical Teoranta
- Deep Blue Medical Advances Inc
- Meccellis Biotech
- PrintBio Inc
- Atrium Medical Corporation
- Cousin Biotech
- Surgical Mesh Technologies Inc
- Gore Medical Bioabsorbables
- MedSkin Solutions Dr Suwelack AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.36 Billion |
| Forecasted Market Value ( USD | $ 1.88 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
